Nimble Science Unveiled as one of Canada's Top 20 Moonshot Ventures™ of 2026 at NACO Summit 2026

14 hours ago
3 min read

OTTAWA, May 6th 2026 08:00 ET | Source: Sabina Bruehlmann, CEO Nimble Science – Today, Nimble Science will be unveiled as one of Canada's Top 20 Moonshot Ventures™ of 2026 at NACO Summit 2026.

Each year, through a nation-wide process led by the National Angel Capital Organization (NACO), Canada’s leading angel groups & incubators, accelerators, and early-stage venture capital funds are invited to nominate high-potential ventures to showcase on the exclusive Moonshots Stage at the NACO Summit.

The Top 20 selected are a cohort of exceptional founders from across the country, who are building transformative solutions across critical sectors, including AI, Healthtech, Fintech, Defence & Dual Use, Quantum Computing, Cleantech, and more.

Nimble Science’s SIMBA Capsule technology represents a paradigm shift in precision medicine, offering the first clinical-grade, at-home solution for assessing small intestinal microbial dysbiosis in patients with chronic GI symptoms, unexplained nutrient deficiencies, or those managing conditions like diabetes and motility disorders. By providing functional metagenomic profiling, SIMBA functions as both an essential clinical assessment tool and a high-fidelity data engine for pharmaceutical and consumer health R&D. The platform integrates spatially and temporally matched datasets into our proprietary GI Data Platform, enabling the rapid identification of novel biomarkers via AI/ML to advance next-generation diagnostics and companion theragnostic solutions.

“To our team, this "moonshot" recognition from NACO validates our ambitious strategy to move beyond the limitations of traditional stool-based diagnostics and access the true epicenter of digestive health. It signifies a pivotal transition from delivering first-in-class data solutions to our global industry partners to a scalable, data-driven platform that empowers clinicians with actionable insights. This designation reinforces our resolve to deliver the global gold standard for small intestinal analysis, ultimately bridging the gap between complex microbiome science and accessible, transformative patient care", says Nimble CEO Sabina Bruehlmann.

About Nimble Science

Nimble Science is a precision medicine company that provides a multi-omic data platform to advance healthcare innovation. Its SIMBA™ Capsule enables unparalleled access to the microenvironment of the small intestine. Nimble's mission is to empower researchers and clinicians with transformative tools to unlock new possibilities in diagnostics and therapeutics. The SIMBA GI Data Platform is available for partnered or independent use to advance research applications.

The company is supported by leading life science investors, including Fusion Fund, Seventure Partners, Ki Tua Fund, and Corundum Systems Biology as well as Canadian ecosystem builders UCeed and Startup TNT.

About NACO

The National Angel Capital Organization (NACO) is Canada’s national industry association for angel investors and early-stage investment organizations, mobilizing private capital to fuel a more prosperous nation of builders. Established in 2002, NACO represents over 4,000 individual investors and serves as the national umbrella for more than 100 member organizations, including angel networks, and early-stage venture funds from coast to coast to coast. NACO’s members have collectively deployed more than CAD $1.8 billion into over 2,000 Canadian ventures, providing the pre-institutional capital that determines whether a company can survive its earliest and most vulnerable stages of growth.

About the Moonshots Stage™

Launched in 2022, the Moonshots Stage™ is Canada’s premier platform for investment-ready Seed and Series A ventures. Unlike traditional pitch events, this showcase puts storytelling front and center - each founder delivers a personal, TED-style presentation designed to spark connection and catalyze opportunity with one of the most curated investor audiences in the country.

Selected companies join the Moonshots Alumni Network™, a national peer community of ventures recognized for innovation, ambition, and global potential. It is a key pillar of NACO Summit, Canada’s most exclusive gathering of early-stage investors and innovation leaders.

www.nimblesci.com

Media Contact:

Nimble Science

1.866.493.4633

Sabina Bruehlmann, CEO

info@nimblesci.com

The company is supported by leading life science investors, including Fusion Fund, Seventure Partners, Ki Tua Fund, and Corundum Systems Biology.